Dishman Pharma to acquire UK firm

The board of directors of Dishman Pharmaceuticals & Chemicals, which met today, approved a proposal to acquire a UK-based contract research company.

According to a release issued by the company to the BSE today, the acquisition will be through the 100% wholly-owned subsidiary - Dishman Europe.

"Managing director J R Vyas has been nominated to negotiate and finalise the terms of the acquisition and execute the necessary documents in this regard," the release added.